Circulating Tumor Cells (CTCs) in Advanced Gastric Cancer

Prediction of Recurrence in Advanced Gastric Cancer After Radical Resection by Circulating Tumor Cells （CTCs）

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01848015

Enrollment

200

Registered

2013-05-07

Start date

2013-06-30

Completion date

2016-06-30

Last updated

2015-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Keywords

CTCs before and after gastrectomy

Brief summary

To assess the predictive value of circulating tumor cells (CTCs) for recurrence of advanced gastric cancer after radical resection. To identify the relationship between the detection of circulation tumor cells and recurrence patterns of gastric cancer after radical resection.

Interventions

OTHERdetection of CTCs

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Having signed informed consent * Age≥ 18 years old * Histologically confirmed gastric adenocarcinoma * Preoperative clinical examination and imaging indicating operable disease * complete resection (R0 resection) * D2 or D2+ resection

Exclusion criteria

* Other tumor type than adenocarcinoma * Patients who have been given preoperative chemotherapy/chemoradiation. * Staging investigations or intraoperative exploration indicating inoperable disease * R1 or R2 resection * D0 or D1 resection * Patients unreliable for follow up * Past history of malignancy

Design outcomes

Primary

Measure	Time frame
CTCs	2 months

Secondary

Measure	Time frame
Recurrence of gastric cancer after radical resection	2 years

Countries

China

Contacts

Primary ContactLin Shen, MD,PhD

lin100@medmail.com.cn(86)10-88196175

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026